CA1239586A - Solution de dialyse contenant des acides amines - Google Patents

Solution de dialyse contenant des acides amines

Info

Publication number: CA1239586A
Authority: CA; Canada
Prior art keywords: amino acids; present; percent; essential; weight
Prior art date: 1984-10-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000464555A

Other languages

English (en)

Inventor

Dimitrios G. Oreopoulos

Gerald H. Anderson

Errol B. Marliss

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-10-02

Filing date

1984-10-02

Publication date

1988-07-26

1984-10-02 Application filed by Individual filed Critical Individual

1984-10-02 Priority to CA000464555A priority Critical patent/CA1239586A/fr

1988-07-26 Application granted granted Critical

1988-07-26 Publication of CA1239586A publication Critical patent/CA1239586A/fr

Status Expired legal-status Critical Current

Links

150000001413 amino acids Chemical class 0.000 title claims abstract description 90
239000000385 dialysis solution Substances 0.000 title claims abstract description 40
239000000203 mixture Substances 0.000 claims abstract description 64
150000003839 salts Chemical class 0.000 claims abstract description 9
229940024606 amino acid Drugs 0.000 claims description 87
235000001014 amino acid Nutrition 0.000 claims description 87
239000003797 essential amino acid Substances 0.000 claims description 53
235000020776 essential amino acid Nutrition 0.000 claims description 52
239000002253 acid Substances 0.000 claims description 14
210000004369 blood Anatomy 0.000 claims description 14
239000008280 blood Substances 0.000 claims description 14
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 13
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 13
235000008729 phenylalanine Nutrition 0.000 claims description 13
229960005190 phenylalanine Drugs 0.000 claims description 13
150000007513 acids Chemical class 0.000 claims description 12
239000004475 Arginine Substances 0.000 claims description 7
229960003767 alanine Drugs 0.000 claims description 7
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 7
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 6
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 6
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 6
239000004473 Threonine Substances 0.000 claims description 6
235000004279 alanine Nutrition 0.000 claims description 6
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 6
229960000310 isoleucine Drugs 0.000 claims description 6
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 5
229930182817 methionine Natural products 0.000 claims description 5
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 6
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 4
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 4
239000004471 Glycine Substances 0.000 claims 3
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 3
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 3
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
239000004472 Lysine Substances 0.000 claims 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 2
239000004474 valine Substances 0.000 claims 2
230000004060 metabolic process Effects 0.000 abstract description 4
208000037157 Azotemia Diseases 0.000 description 16
208000009852 uremia Diseases 0.000 description 16
238000000502 dialysis Methods 0.000 description 15
239000000243 solution Substances 0.000 description 15
235000018102 proteins Nutrition 0.000 description 12
102000004169 proteins and genes Human genes 0.000 description 12
108090000623 proteins and genes Proteins 0.000 description 12
230000008901 benefit Effects 0.000 description 8
150000002500 ions Chemical class 0.000 description 7
235000002639 sodium chloride Nutrition 0.000 description 7
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
239000008103 glucose Substances 0.000 description 5
238000000034 method Methods 0.000 description 5
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
239000004469 amino acid formulation Substances 0.000 description 4
238000009472 formulation Methods 0.000 description 4
235000000346 sugar Nutrition 0.000 description 4
229960004799 tryptophan Drugs 0.000 description 4
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
238000001631 haemodialysis Methods 0.000 description 3
230000000322 hemodialysis Effects 0.000 description 3
239000000463 material Substances 0.000 description 3
235000015097 nutrients Nutrition 0.000 description 3
239000002357 osmotic agent Substances 0.000 description 3
239000011734 sodium Substances 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
239000006035 Tryptophane Substances 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
230000036541 health Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
210000002381 plasma Anatomy 0.000 description 2
239000002243 precursor Substances 0.000 description 2
239000001632 sodium acetate Substances 0.000 description 2
235000017281 sodium acetate Nutrition 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000001540 sodium lactate Substances 0.000 description 2
229940005581 sodium lactate Drugs 0.000 description 2
235000011088 sodium lactate Nutrition 0.000 description 2
230000001954 sterilising effect Effects 0.000 description 2
238000000108 ultra-filtration Methods 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
241000282994 Cervidae Species 0.000 description 1
MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
GGLZPLKKBSSKCX-YFKPBYRVSA-N L-ethionine Chemical compound CCSCC[C@H](N)C(O)=O GGLZPLKKBSSKCX-YFKPBYRVSA-N 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241000282320 Panthera leo Species 0.000 description 1
241000208422 Rhododendron Species 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
235000005550 amino acid supplement Nutrition 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
235000011148 calcium chloride Nutrition 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
230000006735 deficit Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
230000006870 function Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
230000003907 kidney function Effects 0.000 description 1
229940001447 lactate Drugs 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
239000012528 membrane Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
235000021590 normal diet Nutrition 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
-1 palate Chemical compound 0.000 description 1
210000003254 palate Anatomy 0.000 description 1
210000003200 peritoneal cavity Anatomy 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
159000000001 potassium salts Chemical class 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
239000000047 product Substances 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000002699 waste material Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA000464555A 1984-10-02 1984-10-02 Solution de dialyse contenant des acides amines Expired CA1239586A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000464555A CA1239586A (fr)	1984-10-02	1984-10-02	Solution de dialyse contenant des acides amines

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000464555A CA1239586A (fr)	1984-10-02	1984-10-02	Solution de dialyse contenant des acides amines

Publications (1)

Publication Number	Publication Date
CA1239586A true CA1239586A (fr)	1988-07-26

Family

ID=4128823

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000464555A Expired CA1239586A (fr)	1984-10-02	1984-10-02	Solution de dialyse contenant des acides amines

Country Status (1)

Country	Link
CA (1)	CA1239586A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0347714A3 (fr) *	1988-06-22	1990-12-27	Fresenius AG	Solution de dialyse et de rinçage pour l'administration par voie péritonéale
WO1991008008A3 (fr) *	1989-11-30	1991-09-19	Baxter Int	Solution de dialyse peritoneale tamponnee a l'histidine
EP0555087A1 (fr) *	1992-02-04	1993-08-11	Baxter International Inc.	Solutions pour dialyse péritonéale contenant au moins un dipeptide
WO1994014430A1 (fr) *	1992-12-22	1994-07-07	Baxter International Inc.	Solutions d'aminoacides ameliorees destinees au traitement de patients soumis a la dialyse peritoneale

1984
- 1984-10-02 CA CA000464555A patent/CA1239586A/fr not_active Expired

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0347714A3 (fr) *	1988-06-22	1990-12-27	Fresenius AG	Solution de dialyse et de rinçage pour l'administration par voie péritonéale
WO1991008008A3 (fr) *	1989-11-30	1991-09-19	Baxter Int	Solution de dialyse peritoneale tamponnee a l'histidine
EP0555087A1 (fr) *	1992-02-04	1993-08-11	Baxter International Inc.	Solutions pour dialyse péritonéale contenant au moins un dipeptide
US5597805A (en) *	1992-02-04	1997-01-28	Baxter International Inc.	Peritoneal dialysis solutions
EP0804931A3 (fr) *	1992-02-04	2001-04-11	Baxter International Inc.	Solutions pour dialyse péritonéale et leur utilisation pour minimiser des lésions aux cellules mésothéliales
WO1994014430A1 (fr) *	1992-12-22	1994-07-07	Baxter International Inc.	Solutions d'aminoacides ameliorees destinees au traitement de patients soumis a la dialyse peritoneale
US5670176A (en) *	1992-12-22	1997-09-23	Baxter International Inc.	Amino acid solutions for treatment of peritoneal dialysis patients
US5698230A (en) *	1992-12-22	1997-12-16	Baxter International Inc.	Amino acid solutions for treatment of peritoneal dialysis patients
US5776503A (en) *	1992-12-22	1998-07-07	Baxter International Inc.	Amino acid solutions for treatment of peritoneal dialysis patients

Legal Events

Date	Code	Title	Description
2005-07-26	MKEX	Expiry

Publication	Publication Date	Title
AU638527B2 (en)	1993-07-01	Histidine buffered peritoneal dialysis solution
EP0690718B1 (fr)	2003-08-06	Solutions de dialyse peritoneale contenant des maltodextrines et des acides amines
TWI326597B (en)	2010-07-01	Bicarbonate-based solutions for dialysis therapies
EP0176094B1 (fr)	1988-06-29	Solution parentérale alimentaire
US4574085A (en)	1986-03-04	Method for using dialysis solution containing glycerol
AU678201B2 (en)	1997-05-22	Improved amino acid solutions for treatment of peritoneal dialysis patients
CA1168582A (fr)	1984-06-05	Solution de glucose, d'acides amines et d'insuline pour dialyse
WO1987003808A1 (fr)	1987-07-02	Fluides therapeutiques contenant des anions de l-lactate et/ou pyruvate
EP0083360B1 (fr)	1987-04-15	Solution de dialyse peritoneale contenant des polymeres d'hydrate de carbone
AU683863B2 (en)	1997-11-27	Improved peritoneal dialysis solutions with polypeptides
Park et al.	1993	Peritoneal transport during dialysis with amino acid-based solutions
JP3182564B2 (ja)	2001-07-03	栄養組成物
Cancarini et al.	1998	Clinical evaluation of a peritoneal dialysis solution with 33 mmol/L bicarbonate
JPH06509362A (ja)	1994-10-20	アルファ−ケトルグルタル酸塩の用法
Oreopoulos et al.	1982	Nutritional aspects of CAPD and the potencial use of amino containing dialysis solutions.
JPS6330413A (ja)	1988-02-09	アミノ酸輸液用組成物
AU8392382A (en)	1982-11-24	Dialysis solution containing glucose, amino acids & insulin